Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The retrospective cohort study, GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer, published in the August 2025 edition of Oncology , 3 was based on data from 116 patients with a breast cancer diagnosis prescribed GLP-1 RAs at the Memorial Sloan Kettering Cancer Center, from 2015 to 2023
Together, these signaling systems provide a framework for investigating how angiogenic signaling, cytoskeletal organization, and fibroblast-mediated extracellular matrix processes interact in laboratory models of tendon, ligament, and musculoskeletal tissue biology
Trulicity (dulaglutide) Trulicity (dulaglutide) is an injectable GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes
T2D and obesity were not inclusion criteria, but the median BMI was 31 kg/m 2 in the liraglutide group and 33 kg/m 2 in the placebo group
US$ 22.09
US$ 24.53
US$ 27.01
US$ 26.35
US$ 24.40
US$ 22.12
US$ 22.01
